Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 14, Issue 5, Pages 387-394
Publisher
Springer Nature
Online
2012-06-05
DOI
10.1007/s11912-012-0247-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2011) R. Foa et al. BLOOD
- Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
- (2011) F J Giles et al. LEUKEMIA
- First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
- (2010) F. Ravandi et al. BLOOD
- How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2010) A. K. Fielding BLOOD
- Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00
- (2010) Renato Bassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
- (2009) Anthony S. Stein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993
- (2009) Adele K. Fielding et al. BLOOD
- Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
- (2009) J.-M. Ribera et al. HAEMATOLOGICA
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- (2009) Farhad Ravandi et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group
- (2008) T. Burmeister et al. BLOOD
- Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
- (2008) D. K. Hiwase et al. CLINICAL CANCER RESEARCH
- Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2008) M. Mohty et al. HAEMATOLOGICA
- Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia
- (2008) A Shimoni et al. LEUKEMIA
- Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia
- (2008) Shaoguang Li LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search